OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene editing in a Myo6 semi-dominant mouse model rescues auditory function
Yuanyuan Xue, Xinde Hu, Daqi Wang, et al.
Molecular Therapy (2021) Vol. 30, Iss. 1, pp. 105-118
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Advances in gene therapy hold promise for treating hereditary hearing loss
Luoying Jiang, Daqi Wang, Yingzi He, et al.
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 934-950
Open Access | Times Cited: 69

Deafness: from genetic architecture to gene therapy
Christine Petit, Crystel Bonnet, Saaïd Safieddine
Nature Reviews Genetics (2023) Vol. 24, Iss. 10, pp. 665-686
Open Access | Times Cited: 61

Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor
Qingquan Xiao, Zhijiao Xu, Yuanyuan Xue, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 654
Closed Access | Times Cited: 61

Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin
Honghai Tang, Hui Wang, Shengyi Wang, et al.
Human Genetics (2022) Vol. 142, Iss. 2, pp. 289-304
Closed Access | Times Cited: 51

Nanobiomaterial vectors for improving gene editing and gene therapy
Shao Wei Hu, Tao Ding, Honghai Tang, et al.
Materials Today (2023) Vol. 66, pp. 114-136
Closed Access | Times Cited: 24

Hair cell-specific Myo15 promoter-mediated gene therapy rescues hearing in DFNB9 mouse model
Hui Wang, Mengzhao Xun, Honghai Tang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102135-102135
Open Access | Times Cited: 11

AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
Liyan Zhang, Fangzhi Tan, Jieyu Qi, et al.
Advanced Science (2024)
Open Access | Times Cited: 10

Breaking genetic shackles: The advance of base editing in genetic disorder treatment
Fang Xu, Caiyan Zheng, Weihui Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9

Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss
Chong Cui, Daqi Wang, Bowei Huang, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 400-412
Open Access | Times Cited: 34

Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates
Longlong Zhang, Hui Wang, Mengzhao Xun, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101154-101154
Open Access | Times Cited: 18

Mechanisms and otoprotective strategies of programmed cell death on aminoglycoside-induced ototoxicity
Lei Han, Zijing Wang, Daqi Wang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 11
Open Access | Times Cited: 6

Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation
Wenliang Zhu, Wan Du, Arun Prabhu Rameshbabu, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 755
Open Access | Times Cited: 6

Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8
Wan Du, Volkan Ergin, Corena Loeb, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2796-2810
Open Access | Times Cited: 14

Advancements and future prospects of adeno-associated virus-mediated gene therapy for sensorineural hearing loss
Linke Li, Tian Shen, Shixi Liu, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5

From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine
Weihui Xu, Shiyao Zhang, Huan Qin, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Approaches and Vectors for Efficient Cochlear Gene Transfer in Adult Mouse Models
Yu Zhao, Longlong Zhang, Daqi Wang, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 38-38
Open Access | Times Cited: 19

Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges
Roni Hahn, Karen B. Avraham
Audiology Research (2023) Vol. 13, Iss. 6, pp. 952-966
Open Access | Times Cited: 11

Updates on Genetic Hearing Loss: From Diagnosis to Targeted Therapies
Yejin Yun, Sang‐Yeon Lee
Journal of Audiology & Otology (2024) Vol. 28, Iss. 2, pp. 88-92
Open Access | Times Cited: 4

An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism
Nengsong Luo, Kunzhang Lin, Yuxiang Cai, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 303-315
Open Access

In vivo production of CAR T cell: Opportunities and challenges
Zhiqiang Song, Yitong Zhou, Binbin Wang, et al.
Genes & Diseases (2025), pp. 101612-101612
Open Access

Gene Therapy Restores Auditory Functions in an Adult Vglut3 Knockout Mouse Model
Xingle Zhao, Huihui Liu, Hongchao Liu, et al.
Human Gene Therapy (2022) Vol. 33, Iss. 13-14, pp. 729-739
Closed Access | Times Cited: 17

Gene therapy: an emerging therapy for hair cells regeneration in the cochlea
Jipeng Wang, Jianwei Zheng, Haiyan Wang, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9

Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss
Joey Lye, Derek S. Delaney, Fiona K. Leith, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3347-3347
Open Access | Times Cited: 9

Advances in cochlear gene therapies
Miles J. Klimara, Richard J. Smith
Current Opinion in Pediatrics (2023) Vol. 35, Iss. 6, pp. 631-640
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top